| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 6e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |